2022 Recap: A Year For The Books of Infusion 51a
2022 was -no news- a year of economic turmoil, with the global rise in inflation dwarfing all sectors and uncertainty pervading the near-term outlook. The Healthcare sector was not the exception. But, even with the expected lag that comes with the global tightening of the economy, there are many medical wins to celebrate. And, at […]
Getting a Glioblastoma Diagnosis at the Start of the Coronavirus Crisis: The Story of Carol Burkhart
Carol Burkhart was diagnosed with Glioblastoma multiforme (grade IV), the deadliest form of brain cancer, during the early days of the coronavirus outbreak. For us, March 2020 represents the beginning of the pandemic; for her, the start of her cancer journey in the midst of an unprecedented world crisis.
Priorities for the cancer sector and 3 fronts to be addressed in 2022
So we now smoke less, get screened more, and have acknowledged (ish) that preventive healthcare does make the difference. Yet, and regardless of medical technology and cancer death rate falling by nearly a third in the last three decades, cancer continues to be the world-leading cause of death – around 10 million people still die […]
How much do current inflation rates affect me as a private equity investor?
Just like most of the economics questions: it depends. On the sector, the diversification of your portfolio, your return projections, and if you run solo or with a fund.
2021 Recap: a Sweet Year for the Medical Community and Healthcare Investors
2020 triggered it; 2021 consolidated it: the healthcare revolution is only getting started. Both in business and life, the end of the year comes as an opportunity to celebrate your accomplishments and set new milestones. To reflect on how we’ve performed during the last 365 days and acknowledge the adjustments needed for the restart of […]